$QSIM: DD..SEE WHY THIS COULD BE A GREAT MULTI-BAGGER HIGH

New Post Public Reply Private Reply Replies (1) Message Board
SHEEPWOLF
1,286
$QSIM: DD..SEE WHY THIS COULD BE A GREAT MULTI-BAGGER
HIGH ALERT!! PULLBACK TODAY PROVIDES EXCELLENT ENTRY

594260612_QuantumSphere-Technology-QuantumSphere.jpg
1219756660_QSIN~OTC.jpg

QSIM will be Uplisting to NASDAQ in 6-12 months after PIPE Close..QSIM expects Multi $100M in Annual Revenue ...QSIM commercialization in final stages, led by CASALE a 95-year-old engineering firm whose technology is utilized in nearly 40% of the world’s production of ammonia... 10-year renewable commercialization agreement has an approximate up to $75 million annual revenue potential in the ammonia sector thru Casale alone which is represented by up to 15 plants per annum and an anticipated $5 million per plant revenue potential on average...QSIM expects at an approximate $10 million capital expenditure investment can deliver up to $50+ million in additional annual revenue... FeNIX™, commercially validated in existing commercial Chinese ammonia plants for ammonia production in the $100B ammonia industry...QSIM have 10 issued patents and 1 patent pending and also have 4 registered trademarks...QuantumSphere is also leveraging its intellectual property to develop catalysts for other key chemical markets, such as methanol and light olefins..Volume production capacity in place – backed by extensive IP...Collectively, the ammonia (~$100 billion), olefins (~$300 billion) and methanol (~$50 billion) markets represent a ~$450 billion global annual market with several hundred million dollars in total addressable market annually to QSIM!..

The board of directors and advisers (currently) includes a former nobel prize winner and the director of Google Ideas, who was recently one of Time magazines worlds 100 most influential people..

...Float 6,995,307..AS 500,000,000 ...OS 22,965,544 a/o Nov 21, 2016


QSIM's Partner Casale..

http://www.casale.ch/





QSIM CEO's Plans and Objectives near term including Uplisting to NASDAQ!!...



QSIM INVESTOR PRESENTATION..
https://login.uscapitalpartner.net/pub/overvi...nguage=ENG



QSIM CEO Interview..



QSIM'S PARTNER CASALE...
http://www.casale.ch/



credit and thanks to
Nadendla for the DD
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Can Take Charge in Outset Medical Securities Case

Updated Category News Views 226

Investors Can Take Control in Outset Medical Securities Case Investors seeking justice now have a valuable opportunity to take the lead in a class action lawsuit against Outset Medical, Inc. (NASDAQ: OM). This legal effort arises from claims suggesting that the company may not have been fully transparent about its product marketing and operational practices. Understanding...

Continue Reading
Understanding Market Dynamics for IDEXX Laboratories (IDXX)

Updated Category News Views 140

Insights into IDEXX Laboratories Option Trading In recent times, there has been a notable bearish sentiment among major investors regarding IDEXX Laboratories. Taking a closer look at the trading activities surrounding this stock, our attention shifts towards its options market dynamics. Recent Trading Patterns Analyzing the options history for IDEXX Laboratories (NASDAQ:...

Continue Reading
Upcoming Earnings Reports and Market Insights for Investors

Updated Category News Views 164

Key Companies Reporting Earnings Soon As investors gear up for a busy earnings week, a variety of companies are set to disclose their quarterly results. These reports often provide valuable insights into business performance and market trends. Companies Scheduled to Report Before Market Opens So-Young International Inc (NASDAQ: SY) So-Young is anticipated to announce its...

Continue Reading
Intelligent Alpha Launches Innovative AI-Driven ETF for Investors

Updated Category News Views 269

Welcome to Intelligent Alpha and AI-Driven Investments In today's fast-paced investment world, Doug Clinton, co-founder and Managing Partner at Deepwater Asset Management, has introduced Intelligent Alpha, a groundbreaking investment firm focused on utilizing the power of artificial intelligence. This unique firm distinguishes itself by having an investment committee that...

Continue Reading
Investors of Lineage, Inc. (LINE) Consider Class Action Suit

Updated Category News Views 141

Class Action Lawsuit Against Lineage, Inc. In the financial landscape, every investor hopes to see growth in their investments. However, recent developments with Lineage, Inc. have prompted concern among shareholders. It has come to light that some investors may have sustained losses due to alleged securities fraud surrounding the company's performance. As a result, legal...

Continue Reading